Background Peripheral arterial disease (PAD) affects more than 200 million of the global
population. PAD represents a marker for premature cardiovascular events. Patients with …

Aims: To ascertain the effectiveness of medical therapy for reducing risk in peripheral artery
disease (PAD) and to model the potential impact of combining multiple efficacious …

Peripheral artery disease (PAD) commonly refers to atherosclerotic narrowing of
noncoronary arteries, primarily those supplying the lower extremities. The risk factors for …

Aims This study evaluates 10-year follow-up data on associated comorbidity, mortality, and
pharmacological treatment patterns for men and women with different stages of peripheral …

Peripheral arterial disease (PAD) due to atherosclerosis, although frequently ignored in
clinical practice, results in significant cardiovascular morbidity and mortality and may …

Aim Peripheral arterial disease (PAD) is associated with frequent cardiovascular ischemic
events. We followed the survival of PAD patients and tested whether PAD remains an …

Individuals with peripheral arterial disease (PAD) have a significantly elevated risk of
developing major cardiovascular complications, but, until recently, the atherosclerotic …

Objective: Peripheral arterial disease (PAD), an established marker of premature death and
cardiovascular risk in general, is highly prevalent. We analysed factors associated with poor …

Background—Whether individuals with peripheral artery disease (PAD) identified by
screening ankle-brachial index benefit from preventive therapies to reduce cardiovascular …

In the peripheral arteries, a thrombus superimposed on atherosclerosis contributes to the
progression of peripheral artery disease (PAD), producing intermittent claudication (IC) …